CureVac files patent lawsuit against BioNTech over mRNA technology
July 10th, 2022 | 🕒
Convert Text to Speech CureVac sought fair compensation for infringement of a portfolio of its intellectual property rights used for
July 10th, 2022 | 🕒
Convert Text to Speech CureVac sought fair compensation for infringement of a portfolio of its intellectual property rights used for
July 6th, 2022 | 🕒
arabic tts President Biden delivers remarks on COVID-19 vaccines for kids under five. German biopharmaceutical company CureVac sued BioNTech on
January 18th, 2022 | 🕒
iSpeech.org TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / January 17, 2022 / CureVac N.V. (NASDAQ:CVAC), a global biopharmaceutical company
July 4th, 2021 | 🕒
iSpeech CureVac (NASDAQ:CVAC) is working on mRNA coronavirus vaccine candidates. If it's successful, mRNA vaccine giants Moderna and Pfizer will
July 1st, 2021 | 🕒
https://www.ispeech.org Happy Thursday. Futures are muted, signaling that major indexes will open little-changed, ahead of data on jobless claims and
June 16th, 2021 | 🕒
https://www.ispeech.orgCureVac, the latest experimental coronavirus vaccine, proved just 47 percent effective amid spread of variants, preliminary analysis shows The Washington
Gloss